Profil
Makoto Inoue is currently the Director & General Manager-Business Development at Id Pharma Co., Ltd. and a Managing Executive Officer at Sumitomo Chemical Asia Pte Ltd. Previously, he held positions as a Principal at Sumitomo Chemical Co., Ltd. and DNAVEC Research, Inc. Dr. Inoue obtained his doctorate degree from Kyushu University in 1992.
Aktive Positionen von Makoto Inoue
| Unternehmen | Position | Beginn |
|---|---|---|
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Manufactures and sells vaccine and gene therapy | Direktor/Vorstandsmitglied | 01.04.2004 |
Sumitomo Chemical Asia Pte Ltd.
Sumitomo Chemical Asia Pte Ltd. Chemicals: SpecialtyProcess Industries Manufactures and distributes petrochemicals, plastic resins and related products | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Makoto Inoue
| Unternehmen | Position | Ende |
|---|---|---|
DNAVEC Research, Inc. | Corporate Officer/Principal | - |
| SUMITOMO CHEMICAL COMPANY, LIMITED | Corporate Officer/Principal | - |
Ausbildung von Makoto Inoue
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Sumitomo Chemical Co., Ltd.
Sumitomo Chemical Co., Ltd. Chemicals: SpecialtyProcess Industries Manufactures and distributes basic chemicals, petrochemicals, fine and agrichemicals | Process Industries |
Kyushu University
Kyushu University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sumitomo Chemical Asia Pte Ltd.
Sumitomo Chemical Asia Pte Ltd. Chemicals: SpecialtyProcess Industries Manufactures and distributes petrochemicals, plastic resins and related products | Process Industries |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Manufactures and sells vaccine and gene therapy | Health Technology |
DNAVEC Research, Inc. |
















